7-2354993-G-A
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001037283.2(EIF3B):c.72G>A(p.Pro24Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00252 in 1,172,694 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0089 ( 17 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 10 hom. )
Consequence
EIF3B
NM_001037283.2 synonymous
NM_001037283.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.00500
Genes affected
EIF3B (HGNC:3280): (eukaryotic translation initiation factor 3 subunit B) Enables RNA binding activity. Contributes to translation initiation factor activity. Involved in several processes, including IRES-dependent viral translational initiation; translational initiation; and viral translational termination-reinitiation. Located in extracellular exosome. Part of eukaryotic translation initiation factor 3 complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 7-2354993-G-A is Benign according to our data. Variant chr7-2354993-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 787313.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.005 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00892 (1333/149418) while in subpopulation AFR AF= 0.0263 (1084/41236). AF 95% confidence interval is 0.025. There are 17 homozygotes in gnomad4. There are 649 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1333 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EIF3B | NM_001037283.2 | c.72G>A | p.Pro24Pro | synonymous_variant | Exon 1 of 19 | ENST00000360876.9 | NP_001032360.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EIF3B | ENST00000360876.9 | c.72G>A | p.Pro24Pro | synonymous_variant | Exon 1 of 19 | 1 | NM_001037283.2 | ENSP00000354125.4 | ||
EIF3B | ENST00000397011.2 | c.72G>A | p.Pro24Pro | synonymous_variant | Exon 1 of 19 | 1 | ENSP00000380206.2 | |||
EIF3B | ENST00000413917.5 | c.72G>A | p.Pro24Pro | synonymous_variant | Exon 1 of 7 | 2 | ENSP00000407785.1 | |||
EIF3B | ENST00000431643.5 | c.-504-241G>A | intron_variant | Intron 1 of 7 | 5 | ENSP00000408062.1 |
Frequencies
GnomAD3 genomes AF: 0.00891 AC: 1331AN: 149310Hom.: 17 Cov.: 32
GnomAD3 genomes
AF:
AC:
1331
AN:
149310
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00159 AC: 1625AN: 1023276Hom.: 10 Cov.: 29 AF XY: 0.00152 AC XY: 740AN XY: 488212
GnomAD4 exome
AF:
AC:
1625
AN:
1023276
Hom.:
Cov.:
29
AF XY:
AC XY:
740
AN XY:
488212
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00892 AC: 1333AN: 149418Hom.: 17 Cov.: 32 AF XY: 0.00890 AC XY: 649AN XY: 72944
GnomAD4 genome
AF:
AC:
1333
AN:
149418
Hom.:
Cov.:
32
AF XY:
AC XY:
649
AN XY:
72944
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
May 18, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at